Mega Lifesciences Public Company Limited (MEGA.BK)

37,75 -0,25 (-0,66%) Alla chiusura: 04:39PM ICT

Mega Lifesciences Public Company Limited

909, Ample Tower
9th floor Debaratna Road Bangna Nuea, Bangna
Bangkok 10260
Thailand
66 2 769 4222
https://www.megawecare.com

Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno: 

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Vivek Dhawan	CEO, Chief Coach & Executive Director	N/D	N/D	1961
Mr. Thomas Abraham	CFO & Executive Director	N/D	N/D	1963
Mr. Deepak Panjwani	Chief Risk & Compliance Officer	N/D	N/D	1974
Mr. Paramjit Singh Sawhney	President of International	N/D	N/D	1963
Mr. Girish Wadhwa	President of Myanmar	N/D	N/D	1970
Mr. Manoj Gurbuxani	Deputy Chief Financial Officer	N/D	N/D	1974
Ms. Duangnapa Tongsiri	President of Mega We Care Thailand	N/D	N/D	1960
Ms. Sujintana Boonworapat	Corporate Secretary	N/D	N/D	1972

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in THB.

Descrizione

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; eyes, heart, and skin; pain, sleeping, well-being, herbal, and cough and colds; and vitamins, probiotics, medical and sports nutrition, as well as kids', men's, and women's care products. The company also offers prescription medicines in the areas of anti-allergic, anti-infective, central nervous system, cardiovascular system, dermatology, diabetes, gastroenterology, gynecology, nephrology, oncology, ophthalmology, orthopedic, pain, respiratory, rheumatology, and urology. In addition, it provides logistical and marketing services for the sale of goods manufactured by third parties, as well as involved in the software design, development, and other services business. The company was founded in 1982 and is headquartered in Bangkok, Thailand. Mega Lifesciences Public Company Limited operates as a subsidiary of Unistretch Limited.

Governance aziendale

L'ISS Governance QualityScore di Mega Lifesciences Public Company Limited al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.